1.A Case Report of Endobronchial Lipoma.
Jong Mog LEE ; Jong Ho PARK ; Hee Jong BAIK ; Jae Ill ZO
The Korean Journal of Thoracic and Cardiovascular Surgery 1997;30(1):116-118
Endobronchial lipomas are rare lesions that usually obstruct a major bronchus and cause irreversible pulmonary damage distally. They are histologically benign tumors. But they can produce pulmonary damage or irreversible bronchiectasis if dignoses or treatments are delayed. Whenever possible, the treatment of choice is resection by means of bronchoscopy. If endoscopic removal is not possible or if the nature of the tumor is unclear, surgery is necessary, with lobectomy or pneumonectomy being required in most cases due to the extensively damaged pulmonary parenchyma. We present a case of endobronchial lipoma causing bronchial obstruction and peripheral organizing pneumonia with its clinical features, diagnosis and treatment methods.
Bronchi
;
Bronchiectasis
;
Bronchoscopy
;
Diagnosis
;
Lipoma*
;
Pneumonectomy
;
Pneumonia
2.Treatment of Stomach Cancer Involving Esophagogastric Junction.
Jong Mog LEE ; Hee Jong BAIK ; Jong Ho PARK ; Soo Bin YIM ; Jae Ill ZO
The Korean Journal of Thoracic and Cardiovascular Surgery 2001;34(12):930-943
BACKGROUND: The origin site of carcinoma invading esophagogastric junction is variable. It may arise from squamous cell carcinoma of low esophagus, adenocarcinoma arising from Barrett's esophagus, adenocarcinoma of gastric cardia, or extension from proximal stomach cancer. In Korea, the majority of adenocarcinoma invading esophago-gastric junction seems to arise from proximal gastric carcinoma. MATERIAL AND METHOD: We reviewed the data of surgically-resected gastric adenocarcinoma involving esophagogastric junction in KCCH between 1988 and 1999. RESULT: There were 212 cases. Male to female ratio was 156 to 56. Age distribution was between 22 and 78. Variable surgical approaches including median laparotomy, laparotomy with left or right thoracotomy, left thoracotomy, and thoracoabdominal approach were used. Postoperative pathologic stages were : Stage IA-7, IB-11, II-25, IIIA-73, IIIB-34, and IV-57. Curative resection was performed in 199 patients, and total gastrectomy was performed in 200 patients. There were 77.4%(164 cases) with esophageal involvement, 74.1%(157 cases) with tumor involvement in the abdominal LN, and 8%(17 cases) with mediastinal LN metastasis. Operative mortality was 3.3%, and over-all 5 year survival rate was 35%. CONCLUSION: There are various surgical approaches and many things to consider for surgical resection, thoracic and abdominal approach may need for obtain proper resection margin and adequate lymph node dissection in stomach cancer invading esophagogastric junction.
Adenocarcinoma
;
Age Distribution
;
Barrett Esophagus
;
Carcinoma, Squamous Cell
;
Cardia
;
Esophagogastric Junction*
;
Esophagus
;
Female
;
Gastrectomy
;
Humans
;
Korea
;
Laparotomy
;
Lymph Node Excision
;
Male
;
Mortality
;
Neoplasm Metastasis
;
Stomach Neoplasms*
;
Stomach*
;
Survival Rate
;
Thoracotomy
3.Comparison of Inhalation Scan and Perfusion Scan for the Prediction of Postoperative Pulmonary Function.
Young Kug CHEON ; Young Im KWAK ; Jong Gil YUN ; Choon Taek LEE ; Jae Ill ZO ; Young Mog SHIM ; Sang Moo LIM ; Sung Woon HONG
Tuberculosis and Respiratory Diseases 1994;41(2):111-119
BACKGROUND: Because of the common etiologic factor, such as smoking, lung cancer and chronic obstructive Pulmonary disease are often present in the same patient. The preoperative prediction of remaining pulmonary function after the resectional surgery is very important to prevent serious complication and postoperative respiratory failure. 99mTc-MAA perfusion scan has been used for the prediction of postoperative pulmonary function, but it may be inaccurate in case of large V/Q mismatching. We compared 99mTc-DTPA radioaerosol inhalation scan with 99mTc-MAA perfusion scan in predicting postoperative lung function. METHOD: Preoperative inhalation scan and/or perfusion scan were performed and pulmonary function test were performed preoperatively and 2 month after operation. We predicted the postoperative pulmonary functions using the following equations. Postpneumonectomy FEV1=Preop FEV1x% of total function of lung to remain RESULTS: 1) The inhalation scan showed good correlations between measured and predicted FEV1, FVC and FEF25-75%. (correlation coefficiency; 0.94, 0.91, 0.87 respectively). 2) The perfusion scan also showed good correlations between measured and predicted FEV1, FVC and FEF25-75%. (correlation coefficiency; 0.86, 0.72, 0.97 respectively). 3) Among three parameters, FEV1 showed the best correlations in the prediction by lung scans. 4) Comparison between inhalation scan and perfusion scan in predicting pulmonary function did not show any significant differneces except FVC. CONCLUSION: The inhalation scan and perfusion scan are very useful in the prediction of postoperative lung function and don't make a difference in the prediction of pulmonary function although the former showed a better correlation in FVC.
Humans
;
Inhalation*
;
Lung
;
Lung Neoplasms
;
Perfusion*
;
Pulmonary Disease, Chronic Obstructive
;
Respiratory Function Tests
;
Respiratory Insufficiency
;
Smoke
;
Smoking
4.Delayed Gastric Emptying after Esophagectomy: Management and Prevention
Hee Chul YANG ; Jin Ho CHOI ; Moon Soo KIM ; Jong Mog LEE
The Korean Journal of Thoracic and Cardiovascular Surgery 2020;53(4):226-232
The quality of life associated with eating is becoming an increasingly significant problemfor patients who undergo esophagectomy as a result of the improved survival rate afteresophageal cancer surgery. Delayed gastric emptying (DGE) is a common complication afteresophagectomy. Although several strategies have been proposed for the managementand prevention of DGE, no clear consensus exists. The purpose of this review is to presenta brief overview of DGE and to help clinicians choose the most appropriate treatmentthrough an analysis of DGE by cause. Furthermore, we would like to suggest some tips toprevent DGE based on our experience.
5.Transabdominal cardiophrenic lymph node dissection for cytoreductive surgery in advanced ovarian cancer
Hee Chul YANG ; Moon Soo KIM ; Jong Mog LEE ; Jin Ho CHOI ; Sang-Yoon PARK
Journal of Gynecologic Oncology 2022;33(1):e6-
Objective:
Minimizing residual tumors is one of the most important prognostic factors in the management of advanced ovarian cancer [1]. In ovarian cancer patients with cardiophrenic lymph node (LN) metastases, transabdominal cardiophrenic lymph node dissection (CPLND) has been performed along with the surgery on the primary site [2]. However, CPLND for the complicated locations in the thoracic cavity is still technically challenging. This video aims to share our surgical technique for the transabdominal CPLND.
Methods:
A 60-year-old woman who presented with suspicious bilateral ovarian cancer was hospitalized for cytoreductive surgery. Preoperative CT demonstrated peritoneal seeding and multiple LN metastases including right anterior, lateral, posterior, and left anterior cardiophrenic LNs. The gynecology and general surgery team underwent hysterectomy, bilateral salpingo-oophorectomy, supracolic omentectomy, lower anterior resection, right diaphragmatic and bladder peritonectomy, pelvic and paraaortic LN dissection, and appendectomy. The thoracic surgeon took over the operation because the pelvic cavity was regarded as R0. CPLND was performed by transabdominal, subxiphoid approach. The procedure is narrated in the video.
Results:
Complete clearance of CPLN leaving no gross residual disease was possible without complication. A long, transverse incision of the anterior diaphragm was closed with a 1-0 polypropylene in the way of double layered continuous running suture and 8 times ties for the final knot.
Conclusion
Transabdominal CPLND can be used safely and effectively without change of patient's position and with minimal diaphragmatic injury. However, this approach may be unfeasible for metastatic internal mammary LN dissection and still needs meticulous surgical skills to avoid complications.
6.Clinical Characteristics of Malignant Pericardial Effusion Associated with Recurrence and Survival.
Sung Hwan KIM ; Mi Hyang KWAK ; Sohee PARK ; Hak Jin KIM ; Hyun Sung LEE ; Moon Soo KIM ; Jong Mog LEE ; Jae Ill ZO ; Jung Sil RO ; Jin Soo LEE
Cancer Research and Treatment 2010;42(4):210-216
PURPOSE: We evaluated clinical outcomes after drainage for malignant pericardial effusion with imminent or overt tamponade. MATERIALS AND METHODS: Between August 2001 and June 2007, 100 patients underwent pericardiocentesis for malignant pericardial effusion. Adequate follow-up information on the recurrence of pericardial effusion and survival status was available for 98 patients. RESULTS: Recurrence of effusion occurred in 30 patients (31%), all of whom were diagnosed with adenocarcinoma. Multivariate analysis indicated that adenocarcinoma of the lung (hazard ratio [HR], 6.6; 95% confidence interval [CI], 1.9 to 22.3; p=0.003) and progressive disease despite chemotherapy (HR, 4.3; 95% CI, 1.6 to 12.0; p=0.005) were independent predictors of recurrence. Survival rates three months after pericardiocentesis differed significantly with the type of primary cancer; the rates were 73%, 18%, 90% and 30% in patients with adenocarcinoma of the lung, squamous cell carcinoma of the lung, breast cancer and other cancers, respectively. CONCLUSION: Recurrence and survival of patients with malignant pericardial effusion are dependent on the type of primary cancer and response to chemotherapy. Patients with adenocarcinoma of the lung may be good candidates for surgical drainage to avoid repeated pericardiocentesis, but pericardiocentesis is considered effective as palliative management in patients with other cancers.
Adenocarcinoma
;
Breast Neoplasms
;
Carcinoma, Squamous Cell
;
Drainage
;
Follow-Up Studies
;
Humans
;
Lung
;
Multivariate Analysis
;
Pericardial Effusion
;
Pericardiocentesis
;
Prognosis
;
Recurrence
;
Survival Rate
7.Quantitative Evaluation of Post-stroke Spasticity Using Neurophysiological and Radiological Tools: A Pilot Study.
Mi Jin HONG ; Jong Bum PARK ; Yung Jin LEE ; Hyeong Tae KIM ; Won Chul LEE ; Cheol Mog HWANG ; Hyun Kyoon LIM ; Dong Hyun LEE
Annals of Rehabilitation Medicine 2018;42(3):384-395
OBJECTIVE: To determine the possibility of a new measurement tool using electromyography and ultrasonography for quantitative spasticity assessment in post-stroke patients. METHODS: Eight hemiplegic stroke patients with ankle plantarflexor spasticity confirmed by a Modified Ashworth Scale (MAS) were enrolled. Spasticity was evaluated using the MAS and Modified Tardieu Scale (MTS). Each subject underwent surface electromyography (sEMG) using the Brain Motor Control Assessment (BMCA) protocol and was compared with a healthy control group. Using ultrasonography, muscle architecture and elasticity index were measured from the medial gastrocnemius muscle (GCM) on the affected and unaffected sides. RESULTS: MAS and MTS revealed significant correlation with sEMG activity. The fascicle length and pennation angle were significantly decreased in the medial GCM on the hemiplegic side compared with the unaffected side. The elasticity index of the spastic medial GCM was significantly increased compared with the unaffected side. The MTS X and R2–R1 values were significantly correlated with the elasticity index in the hemiplegic GCM. The relationship between clinical evaluation tools and both BMCA and sonoelastography was linear, but not statistically significant in the multiple regression analysis. CONCLUSION: The BMCA protocol and ultrasonographic evaluation provide objective assessment of post-stroke spasticity. Further studies are necessary to conduct accurate assessment and treatment of spasticity.
Ankle
;
Brain
;
Elasticity
;
Elasticity Imaging Techniques
;
Electromyography
;
Evaluation Studies as Topic*
;
Humans
;
Muscle Spasticity*
;
Muscle, Skeletal
;
Muscles
;
Pilot Projects*
;
Stroke
;
Ultrasonography
8.Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for Re-biopsy in Previously Treated Lung Cancer
Joohae KIM ; Hyo Jae KANG ; Sung Ho MOON ; Jong Mog LEE ; Hyae Young KIM ; Geon Kook LEE ; Jin Soo LEE ; Bin HWANGBO
Cancer Research and Treatment 2019;51(4):1488-1499
PURPOSE: Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is widely used for the diagnosis and staging of lung cancer. However, evidence of its usefulness for re-biopsy in treated lung cancer, especially according to the previous treatment, is limited. We evaluated the role of EBUS-TBNA for re-biopsy and its diagnostic values in patients with different treatment histories. MATERIALS AND METHODS: We reviewed the medical records of patients who underwent EBUS-TBNA for re-biopsy of suspicious recurrent or progressive lesions between January 2006 and December 2016 at the National Cancer Center in South Korea. Patients were categorized into three groups based on the previous treatment modalities: surgery, radiation, and palliation. RESULTS: Among the 367 patients (surgery, n=192; radiation, n=40; palliation, n=135) who underwent EBUS-TBNA for re-biopsy, the overall sensitivity, negative predictive value (NPV), and diagnostic accuracy of EBUS-TBNA in detecting malignancy were 95.6%, 82.7%, and 96.3%, respectively. The sensitivity was lower in the radiation group (83.3%) when compared with the surgery (95.7%, p=0.042) and palliation (97.7%, p=0.012) groups. The NPV was lower in the palliation group (50.0%) than in the surgery group (88.5%, p=0.042). The sample adequacy of EBUS-TBNA specimens was lower in the radiation group (80.3%) than in the surgery (95.4%, p < 0.001) or palliation (97.8%, p < 0.001) groups. EGFR mutation analysis was feasible in 94.6% of the 92 cases, in which mutation analysis was requested. There were no major complications. Minor complications were reported in 12 patients (3.3%). CONCLUSION: EBUS-TBNA showed high diagnostic values and high suitability for EGFR mutation analysis with regard to re-biopsy in patients with previously treated lung cancer. The sensitivity was lower in the radiation group and NPV was lower in the palliation group. The complication rate was low.
Biopsy
;
Diagnosis
;
Humans
;
Korea
;
Lung Neoplasms
;
Lung
;
Medical Records
;
Needles
9.Esophagectomy for Esophageal Cancer in Elderly Patients Over 70 Years of Age.
Suk Won SONG ; Hyun Sung LEE ; Moon Soo KIM ; Jong Mog LEE ; Jae Ill ZO
The Korean Journal of Thoracic and Cardiovascular Surgery 2005;38(6):428-433
BACKGROUND: Advanced age in Esophagectomy increases the risk of postoperative morbidity and mortality. However, the recent development of operative technique and perioperative care might have decreased the postoperative morbidity and mortality after esophagectomy. MATERIAL NAD METHOD: From March 2001 to July 2004, 174 patients underwent esophageal resection for esophageal cancer in the Center for Lung Cancer, National Cancer Center. The patients were divided into two groups : group 1 consisted of 27 patients aged 70 years or more, and group 2 consisted of 147 patients under 70 years of age. The two groups were compared according to preoperative risk factors, postoperative morbidity, operative mortality and survival. RESULT: The mean age was 63.4. There were 159 men. On histopathological examination, 93.1% had squamous cell carcinoma. On the locations, 78.7% were in mid and lower esophagus. Curative resections for esophageal cancer were possible in 162 (93.1%) patients. Mean hospital stay was 19.4 days with out difference between the groups. The overall postoperative morbidity were occurred in 61 patients (35.1%). The most frequent morbidity was pulmonary complication in 30 (17.2%). Preoperative incidence of hypertension, cardiac and pulmonary dysfunction were more common in Group I. However, there was no difference in overall postoperative morbidity, operative mortality and survival rate between the two groups. CONCLUSION: Esophagectomy for esophageal cancer could be carried out safely in patients over 70 years of age with satisfactory short-term results. Advanced age is no longer a risk factor for esophagectomy.
Incidence
;
Mortality
;
Risk Factors
;
Lung Neoplasms
;
Esophageal Neoplasms
10.Conservative Treatment with Octreotide as an Adjunct for Chylothorax after Lung Cancer Surgery: Two Cases.
Suk Won SONG ; Hyun Sung LEE ; Moon Soo KIM ; Jong Mog LEE ; Jae Hyun KIM ; Jae Ill ZO
The Korean Journal of Thoracic and Cardiovascular Surgery 2006;39(7):561-564
Postoperative chylothorax is a rare but serious complication of thoracic surgical procedures. We report two cases of chylothorax after lobectomy and mediastinal lymph node dissection for lung cancer. The patients were successfully treated with subcutaneous octreotide injection as an adjunct to conservative treatment.
Chylothorax*
;
Drug Therapy
;
Humans
;
Lung Neoplasms*
;
Lung*
;
Lymph Node Excision
;
Octreotide*
;
Thoracic Surgical Procedures